Does MONTELUKAST Cause Pulmonary vasculitis? 138 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Pulmonary vasculitis have been filed in association with MONTELUKAST (Montelukast). This represents 0.5% of all adverse event reports for MONTELUKAST.
138
Reports of Pulmonary vasculitis with MONTELUKAST
0.5%
of all MONTELUKAST reports
50
Deaths
91
Hospitalizations
How Dangerous Is Pulmonary vasculitis From MONTELUKAST?
Of the 138 reports, 50 (36.2%) resulted in death, 91 (65.9%) required hospitalization, and 136 (98.6%) were considered life-threatening.
Is Pulmonary vasculitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MONTELUKAST. However, 138 reports have been filed with the FAERS database.
What Other Side Effects Does MONTELUKAST Cause?
Asthma (8,372)
Dyspnoea (6,354)
Wheezing (5,159)
Drug ineffective (3,539)
Cough (3,475)
Therapeutic product effect incomplete (3,352)
Anxiety (2,994)
Loss of personal independence in daily activities (2,736)
Sleep disorder due to a general medical condition (2,101)
Obstructive airways disorder (2,073)
What Other Drugs Cause Pulmonary vasculitis?
LEVOFLOXACIN (200)
CALCIUM (197)
ALBUTEROL (194)
PREDNISONE (192)
MAGNESIUM (185)
METFORMIN (185)
FUROSEMIDE (183)
AZATHIOPRINE (178)
DOMPERIDONE (178)
TAMSULOSIN (174)
Which MONTELUKAST Alternatives Have Lower Pulmonary vasculitis Risk?
MONTELUKAST vs MONTELUKAST\MONTELUKAST
MONTELUKAST vs MONTMORILLONITE
MONTELUKAST vs MORNIFLUMATE
MONTELUKAST vs MOROCTOCOG ALFA
MONTELUKAST vs MORPHINE